Pharmafile Logo

Peter Impey

Novartis building

As promised, Novartis’ Entresto is a ‘slow burner’

Inverts typical sales pattern with faster uptake of the drug in Europe than in the US

- PMLiVE

A new route to market

Despite regulation becoming more harmonised, SME expansion still presents complex access challenges

- PMLiVE

Eisai recruits Pfizer and Sanofi execs to neurology group

Appoints Paul Hawthorne and Beyham Zaim to its US subsidiary

HRA Pharma ellaOne campaign

HRA launches ‘fairytale’ digital ad campaign for ellaOne brand

Promotion will run on digital media sites, including the Mail Online

- PMLiVE

Concentric Health Experience eyes European expansion

Appoints Peter Carr and Arron O’Hare as part of regional expansion plans

Two blue birds with speech bubbles containing

Boehringer and Novartis in the running for social media award

Firms are among those shortlisted at PM Society's Digital Awards

- PMLiVE

Pfizer joins up with IBM for internet-of-things collaboration

Aims to develop an IoT remote monitoring system for Parkinson’s patients

- PMLiVE

AbbVie boosts immuno-oncology pipeline with $685m Argenx deal

Buys rights to immuno-suppressive antibody and will fund further research

Roche - Basel

Cancer drugs help Roche beat expectations in first quarter

Sales of Avastin and Herceptin show no sign of slowing down

- PMLiVE

BioAxial appoints president and chief executive officer

Georges Tabary takes up the lead role

- PMLiVE

firstlight appoints Burson-Marsteller’s Christian Petrovic

The agency also recruits Anna Price from Cohn & Wolfe

- PMLiVE

Stepping up to payer-driven market access

Giving the industry an opportunity to secure payers’ endorsements of its products by clearly illustrating product value

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links